-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

626. Aggressive Lymphomas: Clinical and Epidemiological: Poster II

Symposia: Aggressive Lymphomas: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Research, Viral, Combination therapy, Clinical trials, Adult, Clinical Practice (Health Services and Quality), Bispecific Antibody Therapy, Lymphomas, Non-Hodgkin lymphoma, Epidemiology, Genomics, B Cell lymphoma, Clinical Research, Health outcomes research, Diseases, Patient-reported outcomes, Treatment Considerations, Infectious Diseases, Biological therapies, Immunotherapy, Aggressive lymphoma, Real-world evidence, Adverse Events, Lymphoid Malignancies, Non-Biological therapies, Registries, Biological Processes, Technology and Procedures, Study Population, Radiation Therapy, Human, Imaging
Sunday, December 8, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Tomotaka Suzuki1*, Keiichiro Fujii2*, Naohiro Matsunaga3*, Hirokazu Sasaki, MD1*, Takashi Kanamori, MD, PhD3*, Arisa Asano, MD, PhD1*, Shiori Kinoshita, MD, PhD1*, Tomoko Narita, MD, PhD1*, Ayako Masaki, MD.PhD4*, Takaomi Sanda, MD, PhD1, Masaki Ri, MD, PhD1*, Hirokazu Komatsu, MD, PhD1*, Shinsuke Iida, MD, PhD5 and Hiroshi Inagaki4,6*

1Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
2Department of Pathology and Molecular Diagnosis, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
3Department of Hematology and Oncology, Nagoya City University West Medical Center, Nagoya, Japan
4Department of Pathology and Molecular Diagnostics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
5Nagoya City University Institute of Medical and Pharmaceutical Sciences, Nagoya, Japan
6Department of Pathology, Chita Kosei Hospital, Chita, Japan

Matthew Matasar, MD, MS1, David Tucker2, Tae Min Kim, MD, PhD3*, Stefano Luminari4, Yuan Cheng5*, Jingjin Li5*, Saleem Shariff6*, Hesham Mohamed5, Srikanth Ambati5* and Aafia Chaudhry5

1Division of Blood Disorders, Rutgers Cancer Institute and RWJBarnabas Health, New Brunswick, NJ
2Haematology Department, Royal Cornwall Hospital, Truro, United Kingdom
3Seoul National University Hospital, Seoul, Korea, Republic of (South)
4Hematology, Azienda Unità Sanitaria Locale IRCCS of Reggio Emilia, Reggio Emilia, Italy
5Regeneron Pharmaceuticals, Inc., Tarrytown, NY
6Regeneron UK Ltd, Uxbridge, United Kingdom

Hua-Jay J Cherng, MD1, Rebecca Scalabrino, MD2*, Patrick Gould, MD, MBE3*, Alexander Sanjurjo4, Brian Cuzzo, MD3, Saagar Jain4*, Hong Y Ma, MD5*, Maegan Ford, MD, MPH6*, Evelyn H. Orlando, MD7, Dorine De Jong, PhD5*, Manuela A Orjuela, MD8*, Andrew H. Lipsky, MD9, Seda S. Tolu, MD10, Barbara Pro, MD3, Jennifer E. Amengual, MD3 and Kathleen M Capaccione, MD, PhD5*

1Division of Hematology & Oncology, Columbia University Irving Medical Center, Long Island City, NY
2Department of Radiology, Memorial Sloan Kettering Cancer Center, New York
3Division of Hematology & Oncology, Columbia University Irving Medical Center, New York
4Columbia University Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York
5Department of Radiology, Columbia University Irving Medical Center, New York
6Pediatric Hematology-Oncology, Children's Hospital of New Jersey at Beth Israel Medical Center, Newark
7Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY
8Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Columbia University Irving Medical Center, New York
9Herbert Irving Comprehensive Cancer Center, New York-Presbyterian/Columbia University Medical Center, New York, NY
10Division of Hematology & Oncology, Columbia University Irving Medical Center, New York City, NY

Chandran K Nair, MD, DM1*, Lingaraj Nayak, MBBS, MD, DM2*, Anu Korula, MD, DM, MRCP3*, Parathan Karunakaran, MD, DM4*, Abhilash Menon, MD5*, Dubashi Biswajit, MD, DNB, DM6*, Gaurav Prakash, MD, DM7*, Santhosh Kumar Devadas8*, Rayaz Ahmed, MD, DM9, Sunu Cyriac10*, Jansi Rani11*, Hasmukh Jain, MD, DM12*, Sushil Selvarajan, MD, DM13*, Jayachandran Perumal Kalaiyarasi, MD, MBBS, DM, MRCP14*, Nikhil Mohan, MD1*, Prasanth Ganesan, MD, DM15*, Pankaj Malhotra, MD16, Rasmi Palassery, MD17*, Savithri M C10*, Alok Shetty, MD, DM18*, Uday Kulkarni, MD, DM19, Nikita Mehra, MD, DM20*, Smita Kayal, MD, DM21*, Charanpreet Singh, MD, MBBS, DM7*, Punit Jain, MD, DM22*, Aakash Chozakade, MD, DM23*, Tanuja Shet, MBBS, MD, DPB, DNB, DTM24*, Junita Rachel John11*, Krishnarathnam Kannan, MD25*, Sridhar Epari, MD26*, Julie Hepzhibah11*, Uma Sakhadeo, MD24*, Grace Rebekah11*, Om Prakash, MCA27*, Manju Sengar, MD, DM12 and Vikram Mathews, MD, DM28

1Malabar Cancer Centre, Thalassery, India
2Department of Medical Oncology, Tata Memorial Centre, MUMBAI, India
3Department of Haematology, Christian Medical College & Hospital, Vellore, India
4Department of Medical Oncology, Cancer Institute (WIA), Chennai, India
5Medical Oncology, Malabar Cancer Centre, Thalassery, IND
6Jawaharlal Inst. of Postgraduate Medical Edu & Res., Puducherry, IND
7Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
8Medical Oncology, Ramaiah Medical College & Hospital, Bengaluru, IND
9HEMATOLOGY, MAX SUPERSPECIALITY HOSPITAL, DELHI, India
10Amala Institute of Medical Sciences, Thrissur, India
11Christian Medical College , Vellore, Vellore, India
12Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India
13Department of Haematology, Christian Medical College, Vellore, India
14Cancer Institute WIA, Chennai, India
15Department of Medical Oncology, JIPMER, Puducherry, India
16Department of Clinical Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India
17Department of Medical Oncology, MS Ramaiah Medical College, Bengaluru, India
18Department of Medical Oncology, Tata Memorial Centre, Mumbai, India
19Department of Haematology, Christian Medical College Ranipet Campus, Ranipet, India
20Cancer Institute (WIA), Chennai, India
21JIPMER, Puducherry, Puducherry, IND
22Department of Hematology, Apollo Hospitals, Mumbai, Maharashtra, India
23Department of Hematology, Believers Church Medical College Hospital, Thiruvalla, India
24Department of Pathology, Tata Memorial Centre, Mumbai, India
25Cancer Institute(WIA), Adyar, Chennai, IND
26Homi Bhabha National Institute, Mumbai, India
27CMC Vellore, Vellore, India
28Department of Haematology, Christian Medical College Vellore, Ranipet Campus, India

Fan Yang1*, Rui Liu2*, Zhonghua Fu2*, Yuelu Guo2*, Lixia Ma2*, Hui SHI2*, Biping Deng, BS, MD3*, Xiaoyan Ke2* and Kai Hu, MD2

1Department of Lymphoma and Myeloma Research Center, Beijing Gobroad Hospital, Beijing, AL, China
2Department of Lymphoma and Myeloma Research Center, Beijing Gobroad Hospital, Beijing, China
3Department of Cytology Laboratory, Beijing Gobroad Boren Hospital, Beijing, China

Gottfried von Keudell, MD, PhD1, Eliza A. Hawkes, MD2, Cecilia Carpio3*, Max S. Topp4*, Biyi Shen5*, Jingjin Li5*, Claire Hearnden6*, Saleem Shariff7*, Hesham Mohamed5, Srikanth Ambati5, Aafia Chaudhry5 and Sabarish Ayyappan8*

1Beth Israel Deaconess Medical Center, Boston, MA
2Department of Medical Oncology and Clinical Haematology, Olivia Newton-John Cancer Research Institute at Austin Health, Heidelberg, VIC, Australia
3Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain
4Universitätsklinikum Würzburg, Würzburg, Germany
5Regeneron Pharmaceuticals, Inc., Tarrytown, NY
6Regeneron Ireland Ltd., Dublin, Ireland
7Regeneron UK Ltd., Uxbridge, United Kingdom
8City of Hope Cancer Center Atlanta, Newnan, GA

Michal Masar, MD1*, Prokop Vodicka1*, Samuel Hricko, MD2*, Andrea Janikova, MD, PhD3*, Katerina Benesova, MD, PhD1*, David Salek, MD2*, Jana Salkova, MD, PhD1*, Martina Filipova, MD2*, Jan Galko, MD4*, Vit Campr, MD5*, Magdalena Klanova, MD, PhD1,6* and Marek Trneny, MD, CSc7

1First Department of Medicine, First Faculty of Medicine, Charles University and General Hospital, Prague, Czech Republic
2Department of Hematology and Oncology, Faculty of Medicine Masaryk University and University Hospital Brno, Brno, Czech Republic
3Department of Hematology and Oncology, Faculty of Medicine Masaryk University and University Hospital, Brno, Czech Republic
4Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
5Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
6Institute of Pathological Physiology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
7First Faculty of Medicine, Charles University and General Hospital, Prague, Czech Republic

Rintu Sharma, MBBS MD DM1, John Kuruvilla, MD, FRCPC2, Michael Crump, MD2*, David Hodgson, MD3*, Yangqing Deng4*, Abi Vijenthira, MD, SM5, Vishal Kukreti, MD, MSc5, Robert Kridel, MD, PhD2, Rodger E Tiedemann, MBChB, PhD6, Sita Bhella, MD2*, Chloe Yang, MD2* and Anca Prica, MD7

1Division of Medical Oncology and Hematology, Princess Margaret Cancer Center - University Health Network, Toronto, ON, Canada
2Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
3Department of Radiation Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada
4Biostatistics Department, Princess Margaret Cancer Center, Toronto, ON, Canada
5Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
6School of Medical Sciences, Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand
7Divison of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada

Vincent Ni1*, Sunita D. Nasta, MD2, Stefan K. Barta, MD3, Stephen J. Schuster, MD3, Elise A. Chong, MD3, Jakub Svoboda, MD3, Jennifer JD Morrissette, PhD4*, Ashley Barlev, MD4*, Adam Bagg, MD4, Salvatore F. Priore, MD4* and Daniel J. Landsburg, MD3

1School of Arts and Sciences, University of Pennsylvania, Philadelphia, PA
2Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
3School of Medicine, Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA
4School of Medicine, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA

Philip A Haddad, MD1, Jaren Lerner, MD2*, Ankita Gupta, MD3* and Supriya Gupta, MD4

1Feist-Weiller Cancer Center, LSUHSC-S/Overton Brooks VAMC, Shreveport, LA
2LSUHSC-S/Feist-Weiller Cancer Center, Shreveport
3LSUHSC-S/Overton Brooks VAMC, Shreveport
4LSUHSC-S/Feist-Weiller Cancer Center, Shreveport, LA

Lucy Pickard1*, Li Yuan Chan1*, Su Li1*, Michael Potter1*, Emma Nicholson, MD1*, Ian Chau1*, David Cunningham, MD, FRCP, FMedSci1*, Juanah Addada2*, Emily Chernucha2*, Sunil Iyengar3 and Dima El-Sharkawi1*

1Royal Marsden NHS Foundation Trust, London, United Kingdom
2Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
3The Royal Marsden NHS Foundation Trust, London, United Kingdom

Luciana Vinti, PhD1, Jolanda Pianese1*, Elisa Carraro, PhD2*, Paola Muggeo3*, Daniela Onofrillo4*, Irene d'Alba, MD5*, Elisabetta Schiavello6*, Raffaella De Santis7*, Concetta Micalizzi, MD8*, Veronica Barat9*, Katia Perruccio10*, Luca Lo Nigro, MD11, Barbara Buldini, MD, PhD12, Lara Mussolin, PhD13*, Valentina Bertaina, PhD14*, Rita de Vito1*, Marta Pillon, MD, PhD2* and Franco Locatelli, MD1,15

1IRCCS Bambino Gesù Children's Hospital, Rome, Italy
2Padua University Hospital, Pediatric Hematology, Oncology and Stem Cell Transplant Division, Padova, Italy
3U.O.C. di Pediatria ad Indirizzo Oncoematologico, Bari, Italy
4UOSD Oncoematologia Pediatrica, Ospedale Civile Santo Spirito, Pescara, Italy
5Maternal Infant Hospital "G. Salesi", Ancona, Italy
6Fondazione IRCCS Istituto Nazionale Dei Tumori, Milano, Italy
7Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo, Italy
8UOSD Oncoematologia Pediatrica, Ospedale Civile Santo Spirito, Genova, Italy
9SC Onco-Ematologia Pediatrica, AOU Città della Salute e della Scienza, Torino, Italy
10Ospedale SM Misericordia, Perugia, ITA
11Center of Pediatric Hematology Oncology, Azienda Policlinico “San Marco", Catania, Italy
12University of Padova, Padua, Italy
13Pediatric Hematology-Oncology, University of Padua, Padua, Italy
14Department of Hematology-Oncology and Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy
15Catholic University of the Sacred Heart, Rome, Italy

Shaojie Wu1*, Junru Du2*, Jie Ma3*, Li Huang4*, Zhiqiang Peng5*, Yiwen Ling6*, Xiaofang Deng7*, Weijian Zhu8*, Hongliang Li9*, Hua Wang, MD10* and Yuhua Li11*

1Department of Hematology, Zhujiang Hospital of Southern Medical University, Guangzhou, AL, China
2Zhujiang Hospital, Southern Medical University, Guangzhou, China
3Guangxi Medical University, nanning, China
4West China Hospital, Sichuan University, Chengdu, Sichuan, China., chengdu, China
5The Second Affiliated Hospital of Nanchang Medical College, nanchang, China
6The First People’s Hospital of Foshan, foshan, China
7Affiliated Cancer Hospital & Institute of Guangzhou Medical University, guangzhou, China
8Zhuhai People ' s Hospital, zhuhai, China
9Foshan Hospital of Traditional Chinese Medicine, foshan, China
10Sun Yat-sen University Cancer Center, guangzhou, China
11Department of Hematology, Zhujiang Hospital of Southern Medical University, Guangzhou, China

Kristen McClellan, MD1*, Cheryl Chang, BA2*, Anivarya Kumar, BA2*, John Hsu, BA2*, Samantha M Thomas, MS3* and Jie Wang, MD, MS4

1Department of Medicine, Duke University Medical Center, Chapel Hill, NC
2Duke University School of Medicine, Durham, NC
3Department of Biostatistics & Bioinformatics, Duke Cancer Institute, Durham, NC
4Duke Cancer Center, Durham, NC

Nobuhiro Kanemura, MD, PhD1, Toshiki Yamada, MD, PhD2*, Hideko Goto, MD, PhD3*, Takeshi Hara, MD, PhD4*, Senji Kasahara, MD, PhD5, Kenji Fukuno, MD, PhD6*, Michio Sawada, MD, PhD7*, Hiroshi Nakamura, MD, PhD1*, Nobuhiko Nakamura, MD, PhD1*, Shin Lee, MD, PhD4*, Kei Fujita, MD, PhD4*, Tomomi Suzaki, MD5*, Naoki Hayase, MD2*, Takayuki Goto, MD5*, Masahito Shimizu, MD, PhD1* and Hisashi Tsurumi, MD, PhD4

1Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan
2Department of Hematology, Gifu Prefectural General Medical Center, Gifu, Japan
3Department of Hematology, Chuno Kosei Hospital, Gifu, Japan
4Department of Hematology and Oncology, Matsunami General Hospital, Kasamatsu, Japan
5Department of Hematology, Gifu Municipal Hospital, Gifu, Japan
6Department of Hematology, Japanese Red Cross Takayama Hospital, Takayama, Japan
7Department of Hematology, Japanese Red Cross Gifu Hospital, Gifu, Japan

Keita Ishii, MD1*, Kazuhito Suzuki, MD, PhD1, Ryoko Fukushima, MD, PhD2*, Tadahiro Gunji, MD3*, Hiroto Ishii, MD, PhD2*, Masaharu Kawashima, MD, PhD3*, Hideki Uryu, MD1*, Kurumi Tsukamoto, MD3*, Kei Hirano, MD2*, Riku Nagao, MD2*, Hiroki Yokoyama, MD, PhD1*, Atsushi Katsube, MD1*, Susumu Tanoue, MD, PhD1*, Yasutaka Mochizuki, MD1*, Rie Ohba, MD, PhD3*, Daiki Hattori, MD3*, Mitsuji Katori, MD, PhD2*, Takeshi Saito, MD, PhD1, Kaichi Nishiwaki, MD, PhD2*, Nobuaki Dobashi, MD, PhD3 and Shingo Yano, MD, PhD1

1Division of Clinical Oncology/Hematology, The Jikei University Hospital, Tokyo, Japan
2Division of Clinical Oncology/Hematology, The Jikei University Kashiwa Hospital, Chiba, Japan
3Division of Clinical Oncology/Hematology, The Jikei University Daisan Hospital, Tokyo, Japan

Ning Dong, MD MS1, Sushmita Khadka, MD2, Jose Sandoval-Sus, MD3, Carlos Silva Rondon, MD3*, Ariel Perez, MD4*, Tiba Al Sagheer, PharmD4*, Madiha Iqbal, MD5, Juan Pablo Alderuccio, MD6, Cristian Rodriguez Arocho, MD7*, Syeda Saba Kareem, PharmD2*, Michael D. Jain, MD, PhD2 and Julio C. Chavez, MD1

1H Lee Moffitt Cancer Center and Research Institute, Tampa
2H Lee Moffitt Cancer Center & Research Institute, Tampa
3Moffitt Malignant Hematology & Cellular Therapy at Memorial Healthcare System, Memorial Cancer Institute, Pembroke Pines
4Miami Cancer Institute, Baptist Health South Florida, Miami
5Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
6Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
7Auxilio Mutuo Hospital, San Juan

Inna Gong, MD, PhD1, Michael Crump, MD1*, Anca Prica, MD1, Andrew Calzavara2*, Ning Liu, PhD3*, Danielle Rodin, MD, MPH4*, David Hodgson, MD5*, Lee Mozessohn, MD6, Matthew C. Cheung, MD, MSc6 and John Kuruvilla, MD, FRCPC7

1Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
2Institute of Clinical Evaluative Sciences (ICES), Toronto, ON, CAN
3ICES, Toronto, ON, Canada
4Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON, Canada
5Department of Radiation Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada
6Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
7Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada

Samuel Yamshon, MD1*, Jean L. Koff, MD, MSc2, Melissa C. Larson, MS3*, Brad S. Kahl, MD4, Carla Casulo, MD5, Izidore S. Lossos, MD6, Sara Haddadi6*, Michele D. Stanchina, DO, MS7, Dai Chihara, MD, PhD8, Amy A. Ayers, MPH8*, Thomas M. Habermann, MD9, Yucai Wang, MD, PhD9, Arushi Khurana, MBBS9, Grzegorz S. Nowakowski, MD9, Tanner W Reicks3*, Umar Farooq, MD10, Brian K. Link, MD10*, Jonathon B. Cohen, MD, MS11, Peter Martin, MD12, Jia Li, PhD13*, Ashwini Shewade13*, Connie Lee Batlevi, MD, PhD13*, Andrea Lo-Rossi, PhD13*, David Fox13*, Anthony Masaquel13*, Yong Mun13*, James R. Cerhan, MD, PhD3, Christopher R. Flowers, MD, MS8, Matthew J. Maurer, DSc3 and Loretta Nastoupil8*

1Department of Hematology & Medical Oncology, NewYork-Presbyterian/Weill Cornell Medical Center, New York, NY
2Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
3Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
4Department of Medicine, Washington University School of Medicine, St. Louis, MO
5Division of Hematology and Medical Oncology, Wilmot Cancer Institute, University of Rochester, Rochester, NY
6Division of Hematology, Sylvester Comprehensive Cancer Center, Miami, FL
7Sylvester Comprehensive Cancer Center, Division of Hematology, University of Miami, Miller School of Medicine, Miami, FL
8Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
9Division of Hematology, Mayo Clinic, Rochester, MN
10Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
11Winship Cancer Institute, Emory University, Atlanta, GA
12Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY
13Genentech, Inc., South San Francisco, CA

Adit Alpesh Dharia, MBBS, MD1, Vishva M Patel, MBBS2*, Kavya Maddineni3*, Shamitha Hejmadi4*, Dharmik Patel, MBBS, MD5, Rutvik Raval6*, Suraj Kunhipurayil7*, Ishita Hirpara8*, Geethika Potluri9*, Dhruvi Modi10*, Dhruvkumar Gadhiya, MBBS11, Salman Muddassir, MD, FACP12* and Hardik Dineshbhai Desai, MBBS13*

1HCA Florida Oak Hill Hospital, Brooksville, FL
2GMERS Medical College, Gandhinagar, India
3College of Public Health, Kent State University, Kent, OH
4B.J. Medical College, Ahmedabad, India
5HCA Oak Hill Hospital, USF Morsani College of medicine, HCA Oak Hill Hospital, USF Morsani College of medicine, Brooksville, FL
6B.J. Medical College, Ahmeda, India
7St Martinus University Faculty of Medicine, Willemstad, Curacao
8G.M.E.R.S. Medical College, Junagadh, Gujarat, Junagadh,, India
9Duke University,, Durham, NC
10Gujarat Adani Institute of Medical Sciences, Bhuj, India
11Internal Medicine, St.Luke's University Health- Anderson Campus, Easton, PA
12HCA Healthcare/USF Morsani College of Medicine GME: Oak Hill Hospital Program, Brooksville, FL
13Gujarat Adani Institute of Medical Sciences, Affiliated to K.S.K.V University, Bhuj, India, Bhuj, India

Hajime Senjo, MD1, Shinpei Harada, MD2*, Koh Izumiyama, M.D., Ph.D.3*, Hideki Goto, MD, PhD4*, Shiro Watanabe5*, Keito Suto6*, Masayo Yamamoto7*, Kazuya Sato8, Yasutaka Kakinoki, M.D., Ph.D.9*, Tomoyuki Saga10*, Akio Shigematsu, M.D., Ph.D.1,11, Hiroto Horiguchi, MD, PhD12, Mutsumi Takahata13*, Reiki Ogasawara14*, Satoshi Yamamoto, MD, PhD15*, Keisuke Yamaguchi16*, Kentaro Wakasa, M.D., Ph.D.17*, Tetsuyuki Igarashi, M.D.18*, Yoshihito Haseyama19*, Shinichi Ito20*, Katsuya Fujimoto, M.D., Ph.D.21*, Junichi Hashiguchi, M.D.22*, Junichi Sugita, MD, PhD14, Masao Nakagawa, MD, PhD2, Kenji Hirata23*, Takuto Miyagishima24*, Daigo Hashimoto, MD25 and Takanori Teshima, MD, PhD26

1Department of Hematology, Kushiro Rosai Hospital, Kushiro, Japan
2Department of Hematology, Hokkaido University Faculty of Medicine and Graduate School of Medicine, Sapporo, Japan
3Blood Disorders Center, Aiiku Hospital, Sapporo, Japan
4Department of Hematology, Hokkaido University Hospital, Sapporo, Japan
5Department of Nuclear Medicine, Hokkaido University Hospital, Sapporo, Japan
6Department of Hematology, Hokkaido University Faculty of Medicine, Kushiro-Shi Nakazono-Cho, HOK, Japan
7Division of Hematology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Japan
8Department of Hematology/Oncology, Asahikawa Kosei General Hospital, Asahikawa, Japan
9Department of Hematology, Asahikawa City Hospital, Asahikawa, Japan
10Department of Hematology, Kin-ikyo Chuo Hospital, Sapporo, Japan
11Tenshi Hospital, Sapporo, Japan
12Department of Hematology, Sapporo Medical University School of Medicine, Sapporo, Japan
13Department of hematology, Sapporo Kosei General Hospital, Sapporo, Japan
14Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan
15Department of Hematology, Sapporo City General Hospital, Sapporo, Japan
16Department of Hematology, Teine Keijinkai Medical Center, Sapporo, Japan
17Department of Hematology, Obihiro Kosei Hospital, Obihiro, Japan
18Department of Hematology, Tenshi Hospital, Sapporo, Japan
19Department of Hematology, Tonan Hospital, Sapporo, Japan
20Department of Hematology, Hakodate Municipal Hospital, Hakodate, Japan
21Department of Hematology, NHO Hokkaido Cancer Center, Sapporo, Japan
22Department of Internal Medicine, Kitami Red Cross Hospital, Kitami, Japan
23Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, JPN
24Kushiro Rosai Hospital, Kushiro, Japan
25Department of Hematology, Hokkaido University, Sapporo, Japan
26Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan

Alex Tward, BA1*, Roshal R. Patel, MD2*, Irem Isgor, MD3*, Pallavi Galera, MBBS4, Katherine Lopez4*, Beatrice Fregonese, MPH5*, Zachary Moore, MD, PhD5*, Suzanne Wolden, MD5*, Joachim Yahalom, MD5 and Brandon S. Imber, MD, MA5

1Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York City, NY
2Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Pathology and Laboratory Medicine, Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York
4Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
5Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY

Hilary A Elom, MD1*, Tarfa Verinumbe, MBBS2*, Elvis Obomanu, MBBS3*, Hasiya Yusuf, MD4*, Colton Frisco Jones5,6* and Monika Kulasekaran, MD7

1University of Missouri School of Medicine, Columbia, MO
2John Hopkins University, Baltimore
3Jefferson-Einstein Hospital, Philadelphia, PA
4Albert Einstein College of Medicine/Jacobi Medical Center, Bronx, NY
5Albert Einstein Medical Center, Philadelphia, PA
6Thomas Jefferson University Hospital, Philadelphia, PA
7University of Missouri School of Medicine, Baltimore, MD

Peter Braendstrup, MD, PhD1*, Thomas Bech Mortensen2*, Tarec Christoffer El-Galaly, MD, DMSc, Prof3,4,5, Michael Boe Møller6*, Judit Mészáros Joergensen, MD, PhD7*, Christian Bjørn Poulsen, MD, PhD8*, Peter de Nully Brown, MD, PhD9,10, Dennis Lund Hansen, MD, PhD5* and Thomas Stauffer Larsen, MD, PhD11*

1Department of Hematology, Odense University Hospital, Department of Hematology, Denmark, Odense C, Denmark
2Odense University Hospital, Department of Hematology, Denmark, Odense C, DNK
3Department of Hematology, Aalborg Hospital, Aalborg, Denmark
4Dept. of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark
5Department of Clinical Research, University of Southern Denmark, Odense, Denmark
6Pathology, Odense University Hospital, Odense, Denmark
7Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
8Department of Hematology, Zealand University Hospital, Roskilde, Denmark, Roskilde, DNK
9Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Denmark, Copenhagen, Denmark
10Dept. of Hematology, Rigshospitalet, Copenhagen, Denmark
11Department of Hematology, Odense University Hospital, Odense, Denmark

*signifies non-member of ASH